Public Summary Document redactions: You are being set-up

March 6, 2020 Comment

The industry cannot selectively enforce its rights under the secrecy provisions - there must be a consistent approach and it should respond to the redactions push in the context of likely issues in the future, such as the inevitable push for price transparency. …

Latest Video

New Stories

And this is why it's very hard not to be cynical in this system because this committee gets to set its own rules
November 11, 2026 - - Latest News
The negotiating room is getting smaller as officials narrow the scope
November 11, 2026 - - Latest News
PBAC sets out its expectations for AI in medicines submissions
November 11, 2026 -
And this is why it's very hard not to be cynical in this system becasue this committee gets to set its own rules
November 11, 2026 - - Latest News
Dispatch AI Index finds routine AI use but questions over governance
November 10, 2026 - - News of the Day
Mayne Pharma sells Salisbury business to Evaris Pharma for $55.5 million
November 10, 2026 - - Latest News
Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia
November 10, 2026 - - Latest News

Public Summary Document redactions: You are being set-up

Latest Video

Most Read

Celairis launches with plan to end the region's place at the rear of the launch queue

Pfizer confirms Ben Fitzsimmons as Australia and New Zealand chief

Pfizer commissioned polling finds strong public support for investing in the PBS

Coalition edges ahead in New Zealand as Stephenson returns and Pharmac pledges await the 'specials'

Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia

New Stories

And this is why it's very hard not to be cynical in this system because this committee gets to set its own rules

The negotiating room is getting smaller as officials narrow the scope

PBAC sets out its expectations for AI in medicines submissions

And this is why it's very hard not to be cynical in this system becasue this committee gets to set its own rules

Dispatch AI Index finds routine AI use but questions over governance

Mayne Pharma sells Salisbury business to Evaris Pharma for $55.5 million

Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia

Sign In

Public Summary Document redactions: You are being set-up

This is a preview of subscriber content

Latest Video

Most Read

Celairis launches with plan to end the region's place at the rear of the launch queue

Pfizer confirms Ben Fitzsimmons as Australia and New Zealand chief

Pfizer commissioned polling finds strong public support for investing in the PBS

Coalition edges ahead in New Zealand as Stephenson returns and Pharmac pledges await the 'specials'

Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia

Follow Us

New Stories

And this is why it's very hard not to be cynical in this system because this committee gets to set its own rules

The negotiating room is getting smaller as officials narrow the scope

PBAC sets out its expectations for AI in medicines submissions

And this is why it's very hard not to be cynical in this system becasue this committee gets to set its own rules

Dispatch AI Index finds routine AI use but questions over governance

Mayne Pharma sells Salisbury business to Evaris Pharma for $55.5 million

Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia